Womens Health Diagnostics Market Trends, Dynamics, Drivers, Competitive landscape and Future Opportunities
The global
women’s health diagnostic market is witnessing considerable growth due
to increasing geriatric population, increasing healthcare expenditure,
increasing incidence of lifestyle diseases in women and growing awareness among
women about various health disorders. Moreover, growing prevalence of
infectious diseases in women including hepatitis and HIV is supporting the
growth of the market. Based on application, the prenatal genetic screening and
carrier test segment is expected to grow at the fastest rate during the forecast
period. The increasing awareness about these tests is driving the growth of
this segment.
Geographically, North America has been the largest market
for women’s health diagnostic owing to increased awareness, established
healthcare industry, and increasing prevalence of cancer in this region. The
U.S. contributed largest revenue to the North American as well as global
women’s health diagnostic market. The increasing incidence of lifestyle related
health disorders and increasing demand for fertility test is the key growth
driving factor of the U.S. women’s health diagnostic market.
Request to Get the Sample Pages at:
Europe has been the second largest market for women’s health
diagnostic, where the market is driven by the presence of a large pool of
cancer patients, increasing healthcare expenditure and rapidly developing
healthcare infrastructure. In 2015, Germany led the European women’s health
diagnostic market and it is also expected to grow at the fastest rate in
Europe, during forecast period.
Globally, the women’s health diagnostic market
in Asia-Pacific is expected to witness highest growth during the forecast
period. The highest growth in the region is attributed to the increasing
prevalence of chronic diseases, increasing per capita income leading to
increasing standard of living, increasing healthcare spending, growing demand
for better quality medical care, and awareness about women’s health diagnostic
tests in the region.
The key players operating in the global women’s health
diagnostic market are F. Hoffmann-LA Roche AG, Siemens AG, Hologic, Inc., Quest
Diagnostics Inc., Alere Inc., Perkinelmer, Inc., GE Healthcare, Koninklijke
Philips N.V., Abbott Laboratories, Becton, Dickinson and Company and Biomérieux
SA.
Comments
Post a Comment